Literature DB >> 12368090

Transglutaminase 2: an enigmatic enzyme with diverse functions.

Laszlo Fesus1, Mauro Piacentini.   

Abstract

Transglutaminase 2 (TG2) is an inducible transamidating acyltransferase that catalyzes Ca(2+)-dependent protein modifications. It acts as a G protein in transmembrane signalling and as a cell surface adhesion mediator, this distinguishes it from other members of the transglutaminase family. The sequence motifs and domains revealed in the recent TG2 structure, can each be assigned distinct cellular functions, including the regulation of cytoskeleton, cell adhesion and cell death. Ablation of TG2 in mice results in impaired wound healing, autoimmunity and diabetes, reflecting the number and variety of TG2 functions. An important role for the enzyme in the pathogenesis of coeliac disease, fibrosis and neurodegenerative disorders has also been demonstrated, making TG2 an important therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368090     DOI: 10.1016/s0968-0004(02)02182-5

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  152 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  New weapons against inflammation: dual inhibitors of phospholipase A2 and transglutaminase.

Authors:  Lucio Miele
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  Characterization of transglutaminase type II role in dendritic cell differentiation and function.

Authors:  Ivana Matic; Alessandra Sacchi; Alessandra Rinaldi; Gennaro Melino; Chaitan Khosla; Laura Falasca; Mauro Piacentini
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

4.  In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.

Authors:  Miho Itoh; Tadafumi Kawamoto; Hideki Tatsukawa; Soichi Kojima; Kiyofumi Yamanishi; Kiyotaka Hitomi
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

5.  Tissue transglutaminase inhibits the TRPV5-dependent calcium transport in an N-glycosylation-dependent manner.

Authors:  Sandor Boros; Qi Xi; Henrik Dimke; Annemiete W van der Kemp; Kukiat Tudpor; Sjoerd Verkaart; Kyu Pil Lee; René J Bindels; Joost G Hoenderop
Journal:  Cell Mol Life Sci       Date:  2011-09-28       Impact factor: 9.261

6.  The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

Authors:  Sara Altuntas; Federica Rossin; Claudia Marsella; Manuela D'Eletto; Laura Diaz-Hidalgo; Maria Grazia Farrace; Michelangelo Campanella; Manuela Antonioli; Gian Maria Fimia; Mauro Piacentini
Journal:  Oncotarget       Date:  2015-12-29

7.  Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.

Authors:  Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

8.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

9.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

10.  Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2.

Authors:  Zsolt Keresztessy; Eva Csosz; Jolán Hársfalvi; Krisztián Csomós; Joe Gray; Robert N Lightowlers; Jeremy H Lakey; Zoltán Balajthy; László Fésüs
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.